Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review

  • ID: 2300615
  • SWOT Analysis
  • 45 pages
  • GlobalData
  • Siegfried Holding AG
1 of 5

FEATURED COMPANIES

  • Bachem Holding AG
  • IBR Inc
  • Jetpharma SA
  • Lonza Group Ltd
  • Perrigo Company Plc
  • PharmaZell GmbH
  • MORE
Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. Siegfried also offers development and production services for finished dosage forms including sterile filling. It serves principally companies operating in pharmaceutical industry. It has production facilities in the USA, Switzerland, Malta, China, Germany and France. The company offers its products in USA Europe and other countries. Siegfried is headquartered in Zofingen, Aargau Switzerland.

Siegfried Holding AG Key Recent Developments

Aug 21, 2018: Siegfried reports higher sales and further improved margin for first half year
Jun 04, 2018: Siegfried Group: Change in the Executive Committee
Mar 14, 2018: Siegfried with Sales and Margin Growth
Aug 23, 2017: Siegfried Reports Higher Profit and Increased Margin for First Six Months
Mar 21, 2017: Siegfried Group: Management Changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bachem Holding AG
  • IBR Inc
  • Jetpharma SA
  • Lonza Group Ltd
  • Perrigo Company Plc
  • PharmaZell GmbH
  • MORE
Section 1 - About the Company

Siegfried Holding AG - Key Facts
Siegfried Holding AG - Key Employees
Siegfried Holding AG - Key Employee Biographies
Siegfried Holding AG - Major Products and Services
Siegfried Holding AG - History
Siegfried Holding AG - Company Statement
Siegfried Holding AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview
Siegfried Holding AG - Business Description
Product Category: Drug Substances
Overview
Performance
Product Category: Drug Products
Overview
Performance
R&D Overview
Siegfried Holding AG - Corporate Strategy
Siegfried Holding AG - SWOT Analysis
SWOT Analysis - Overview
Siegfried Holding AG - Strengths
Siegfried Holding AG - Weaknesses
Siegfried Holding AG - Opportunities
Siegfried Holding AG - Threats
Siegfried Holding AG - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Siegfried Holding AG, Recent Deals Summary

Section 5 - Company’s Recent Developments

Aug 21, 2018: Siegfried reports higher sales and further improved margin for first half year
Jun 04, 2018: Siegfried Group: Change in the Executive Committee
Mar 14, 2018: Siegfried with Sales and Margin Growth
Aug 23, 2017: Siegfried Reports Higher Profit and Increased Margin for First Six Months
Mar 21, 2017: Siegfried Group: Management Changes
Mar 14, 2017: Siegfried with Jump in Sales in 2016

Section 6 - Appendix

Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables

Siegfried Holding AG, Key Facts
Siegfried Holding AG, Key Employees
Siegfried Holding AG, Key Employee Biographies
Siegfried Holding AG, Major Products and Services
Siegfried Holding AG, History
Siegfried Holding AG, Subsidiaries
Siegfried Holding AG, Key Competitors
Siegfried Holding AG, Ratios based on current share price
Siegfried Holding AG, Annual Ratios
Siegfried Holding AG, Annual Ratios (Cont...1)
Siegfried Holding AG, Annual Ratios (Cont...2)
Siegfried Holding AG, Interim Ratios
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Siegfried Holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Siegfried Holding AG, Performance Chart (2013 - 2017)
Siegfried Holding AG, Ratio Charts
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 3
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Bachem Holding AG
  • Corden Pharma Switzerland LLC
  • IBR Inc
  • Jetpharma SA
  • Legacy Pharmaceuticals Switzerland GmbH
  • Lonza Group Ltd
  • Perrigo Company Plc
  • PharmaZell GmbH
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll